Elizabeth M Poole

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Genetic variability in IGF-1 and IGFBP-3 and body size in early life
    Elizabeth M Poole
    Department of Medicine, Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    BMC Public Health 12:659. 2012
  2. pmc Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3
    Elizabeth M Poole
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
    Am J Epidemiol 174:642-51. 2011
  3. pmc Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project
    Elizabeth M Poole
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Breast Cancer Res Treat 139:529-37. 2013
  4. pmc Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness
    Elizabeth M Poole
    Corresponding Author Elizabeth M Poole, Channing Laboratory, 181 Longwood Ave, 3rd Floor, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 22:429-37. 2013
  5. pmc ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium
    Elizabeth M Poole
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 181 Longwood Ave, 3rd Floor, Boston, MA 02115, USA
    Cancer Causes Control 23:1805-10. 2012
  6. pmc The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics
    Sarah J Nechuta
    Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37203 1738, USA
    Cancer Causes Control 22:1319-31. 2011
  7. pmc Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control study
    Jing Xie
    Corresponding Author Shelley S Tworoger, Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115
    Cancer Epidemiol Biomarkers Prev 22:653-60. 2013
  8. pmc Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer
    Elizabeth M Poole
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Epidemiol 36:e104-10. 2012
  9. pmc Rotating night shift work and risk of ovarian cancer
    Elizabeth M Poole
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 20:934-8. 2011

Detail Information

Publications9

  1. pmc Genetic variability in IGF-1 and IGFBP-3 and body size in early life
    Elizabeth M Poole
    Department of Medicine, Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    BMC Public Health 12:659. 2012
    ..Previous studies have examined the role of IGF-1 and IGFBP-3 genetic variation in relation to adult height and body size, but few studies have examined associations with birthweight and childhood size...
  2. pmc Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3
    Elizabeth M Poole
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
    Am J Epidemiol 174:642-51. 2011
    ..These findings suggest that altered IGF-1 levels in adulthood may be a mechanism through which early-life body size influences subsequent breast cancer risk...
  3. pmc Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project
    Elizabeth M Poole
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Breast Cancer Res Treat 139:529-37. 2013
    ..Stratification by ER status and considering antioxidants as a group may be more clinically relevant when evaluating associations with cancer risk and mortality...
  4. pmc Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness
    Elizabeth M Poole
    Corresponding Author Elizabeth M Poole, Channing Laboratory, 181 Longwood Ave, 3rd Floor, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 22:429-37. 2013
    ....
  5. pmc ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium
    Elizabeth M Poole
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 181 Longwood Ave, 3rd Floor, Boston, MA 02115, USA
    Cancer Causes Control 23:1805-10. 2012
    ..Previous studies have examined the association between ABO blood group and ovarian cancer risk, with inconclusive results...
  6. pmc The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics
    Sarah J Nechuta
    Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37203 1738, USA
    Cancer Causes Control 22:1319-31. 2011
    ..The project sets the stage for international collaborations for the investigation of modifiable predictors for breast cancer outcomes...
  7. pmc Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control study
    Jing Xie
    Corresponding Author Shelley S Tworoger, Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115
    Cancer Epidemiol Biomarkers Prev 22:653-60. 2013
    ..Two large prospective cohort studies of dietary acrylamide intake and ovarian cancer risk observed a positive association, although two other studies reported no association...
  8. pmc Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer
    Elizabeth M Poole
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Epidemiol 36:e104-10. 2012
    ..These data provide some evidence that genetic variability in IL23R may contribute to rectal cancer risk and should be evaluated in additional studies...
  9. pmc Rotating night shift work and risk of ovarian cancer
    Elizabeth M Poole
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 20:934-8. 2011
    ..Night shift work has been associated with higher risks of breast and endometrial cancer, but few studies have evaluated associations with other reproductive cancers...